Cnoga Medical News
5 articles
growth-positive
Israeli device banishes finger-pricking for sugar levels in diabetes patients
Caesarea-based startup Cnoga Medical has developed a noninvasive glucose meter that uses a camera to track blood glucose levels without pricking or pain. The device has received regulatory certifications in the European Union, Brazil, and China, and the company plans to seek FDA approval in 2018. Clinical trials have shown that the device performs with a surprising level of accuracy, comparable to invasive needle sensors. The technology has the potential to revolutionize blood glucose monitoring for diabetes patients, providing a pain-free alternative to current methods. Cnoga has raised $63 million in funding from investors including Texas Instruments, the BIRD Foundation, Go Capital Ltd., and BOE Technology Group.
Customers
growth-positive
To Mark World Diabetes Day, Israeli Company Promotes Needle-Free Glucose Test
Israeli medical company Cnoga Medical is promoting its non-invasive glucometer that uses a camera to monitor blood glucose levels. The device offers accurate results comparable to fingerprick tests without the need for needles. Cnoga raised $50 million from Chinese company BOE for 23% of its shares earlier this year. The company aims to provide a better quality of life for the 400 million people worldwide living with diabetes.
CustomersInvestment
growth-positive
Cnoga Medical raises $50m from China's BOE
Chinese company BOE has invested $50 million in Israeli company Cnoga Medical for 23% of the companys shares, reflecting a company value of $217 million. The deal also includes the signing of an agreement for joint marketing of Cnogas products in China and development of a new line of products for the professional health market. Cnoga has developed a series of devices for non-invasive measurement of health parameters through optical diagnosis of the changing color shades of a finger. The companys products are distributed in several countries and are approved for marketing in 35 countries. Cnoga was founded by Dr. Yosef Segman, who previously founded OPlus Technologies.
InvestmentPartners
growth-positive
Diabetes diagnosis co CNoga Medical raises $12.5m
Israeli company CNoga Medical has completed a $12.5 million financing round from Chinese investment fund GoCapital. CNoga has developed a device that uses the patients skin color to diagnose high blood pressure and measure blood sugar levels without puncturing the skin. The investment will enable the company to expedite the development of the next generation of devices and expand its marketing and business development apparatus, with a focus on European and Asian markets, especially China.
InvestmentExpand
growth-positive
Cnoga Medical develops diagnostics through skin color
Cnoga Medical Ltd., founded by Dr. Yosef Segman, has developed a non-invasive blood sugar monitor. The device uses algorithms to analyze images of skin color for diagnostic purposes. The company has raised $8 million from investors including Texas Instruments and the Israel-United States Binational Industrial Research and Development Foundation (BIRD-F). The monitor has received FDA approval and the company has begun sales in the US through distributors. However, the device is not yet approved in the US for measuring blood sugar, which is limiting the companys growth. Cnoga Medical is considering expanding into the cosmetics and homeland security markets in the future.
InvestmentCustomersPartners
